drug prices Archives - Health Issues India

Biden weighs in on drug costs in US; The latest health stories from around the world

Leave a Comment / Access to Healthcare, Covid-19, Featured, Featured Story, Government policy, Infectious diseases, International, Medicine and Research, News, Newsletter, Noncommunicable diseases / By Lalita Panicker

US President Joe Biden has stepped into a long-running debate about whether the National Institutes of Health (NIH) has legal authority to override an exclusive patent license granted to drug developers if they charge too much for treatments that relied on agency-funded research. In draft policy guidance, the Biden administration says federal agencies would be …

Biden weighs in on drug costs in US; The latest health stories from around the world Read More »

Paracetamol prices spike amidst COVID-19 outbreak

Leave a Comment / Featured, Infectious diseases, International, Medicine and Research, National, News, Science and Technology, Social issues / By Editor, Health Issues

The COVID-19 outbreak that originated China and has since mushroomed to several countries worldwide – including India – has had a knock-on effect on multiple industries including the pharmaceutical industry. This ripple effect has manifested in a spike in paracetamol prices. At the time of writing, COVID-19 has infected in excess of 73,000 and resulted …

Paracetamol prices spike amidst COVID-19 outbreak Read More »

Ban on Oxytocin postponed – again

Leave a Comment / Access to Healthcare, Featured Stories, Government policy, Medicine and Research, National, News, Social issues / By Editor, Health Issues

The Centre’s ban on hormone drug Oxytocin was supposed to come into force today, but has been stayed till October by the Delhi High Court (DHC). The news will surely come as a relief to activists, doctors and drugmakers opposing the Centre’s decision to tighten restrictions on the drug’s production and sale in India. Many …

Ban on Oxytocin postponed – again Read More »

Centre lifts ban on sales of life-saving drug Oxytocin

Leave a Comment / Access to Healthcare, Featured Stories, Government policy, Medicine and Research, National, News, Social issues / By Editor, Health Issues

The Centre has revoked its decision to ban retail sale of Oxytocin, a life saving drug for pregnant women in India after petitioners moved court. But tight restrictions remain in place. Oxytocin is a hormone drug used in the treatment of postpartum haemorrhage (PPH), the predominant cause of maternal mortality in India. Its misuse in …

Centre lifts ban on sales of life-saving drug Oxytocin Read More »

Oxytocin: The strange case of India’s ban

Leave a Comment / Access to Healthcare, Featured, Featured Stories, Government policy, Medicine and Research, National, News, Social issues / By Editor, Health Issues

The Centre has been encouraged to scrap its controversial ban on private sector sales of Oxytocin by the Drug and Technical Advisory Board (DTAB). In a stunning u-turn from the body’s previous stance, it is now exhorting the health ministry to ensure that the hormone drug is “[available] for human use.” Oxytocin is used to …

Oxytocin: The strange case of India’s ban Read More »

US and India’s relationship souring over price capping?

1 Comment / Access to Healthcare, Featured, Government policy, International, News / By Editor, Health Issues

Just a few months ago the relationship between India and the US was touted by President Donald Trump as having “never been stronger”. Will India’s policy of price capping medical devices sour this relationship? The US Trade Representative (USTR) is reportedly considering revoking the special tariff with India if it continues to implement price caps …

US and India’s relationship souring over price capping? Read More »

Drug producers to be required to display manufacturing cost

Leave a Comment / Access to Healthcare, Featured, Government policy, Medicine and Research, National, News, Social issues / By Editor, Health Issues

In a move that is already causing distress amongst pharmaceutical companies, India’s Health Ministry is putting in motion requirements for all drugs to display the manufacturing costs on the label. This would bring not only the costs of manufacture, but the assumed profit margins of the medication into the public domain. The Central Drugs Standard …

Drug producers to be required to display manufacturing cost Read More »

India is fighting at the WHO to make medicines cheaper, but drug quality is the real problem

Leave a Comment / Access to Healthcare, Featured, Government policy, International, Medicine and Research, News, Opinion / By Editor, Health Issues

This has been reproduced, with permission, from The News Minute. Full credit goes to the author Ramanathan S. (@madrassi). The original article can be accessed here Not very far from the Serpentine Bar at the Palace of Nations in Geneva, the United Nations HQ, where both lobbyists of the private sector and non-state actors are competing …

India is fighting at the WHO to make medicines cheaper, but drug quality is the real problem Read More »

Bucking the trend: Is India’s drug market back on the up?

Leave a Comment / Access to Healthcare, Featured, Government policy, International, Medicine and Research, National, News / By Editor, Health Issues

“Bucking the trend” India’s drug market is starting to show signs of improvement after a rough few months, with everything from demonetisation to Donald Trump taking its toll. However, the future remains very much unclear. Demonetisation The Indian pharmaceutical market (IPM) is “bucking the trend of a sequential decline” according to MoneyControl, growing 9.6 percent …

Bucking the trend: Is India’s drug market back on the up? Read More »

Trump’s triumph emboldens Indian pharma experts

Leave a Comment / Featured, International, Medicine and Research, News / By Editor, Health Issues

The unexpected victory of Donald Trump in the U.S. presidential election has sent shockwaves reverberating throughout the world – but it has been suggested by some that his win is good news for Indian drugmakers. The President elect’s rhetoric on the campaign trail was often inflammatory and controversial. It included blaming India and China for …

Trump’s triumph emboldens Indian pharma experts Read More »

Offer An Article

Pandemic Latest News

drug prices

US and India’s relationship souring over price capping?

India is fighting at the WHO to make medicines cheaper, but drug quality is the real problem

Bucking the trend: Is India’s drug market back on the up?

Trump’s triumph emboldens Indian pharma experts

About Us

Newsletter